Data Factory
Reading the graph
Reading the graph
Venture Capital
Bala Cynwyd, PA
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| Garden State Life Sciences Venture Fund, L.P. | n/a | Wound down | n/a | $1.3M | 0 |
| Quaker Bioadvance Ventures, L.P. | n/a | Wound down | n/a | $287,357 | 0 |
| Quaker Bioventures, L.P. | n/a | Wound down | n/a | $1.1M | 1 |
| Quaker Bioventures II, L.P. | n/a | Unknown | n/a | $7.0M | 0 |
| Quaker Bioventures Tobacco Fund, L.P. | n/a | Wound down | n/a | $136,543 | 0 |
Also named here, with no published line of their own (reach them through the firm): Brian Richard Schwenk (Chief Financial Officer), Paul Sherrill Neff (Member), IRA Mark Lubert (Member), Howard David Ross (Limited Partner), Seth Jonathan Lehr (Limited Partner), Mitchell Louis Hollin (Limited Partner), Richard Scott Kollender (Member), Adele Cirone Oliva (Member), Michelle Woods Vaughn (Chief Compliance Officer).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan